Actively Recruiting
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D-Afg]: Feasibility Trial in Rural Kabul-Afghanistan
Led by HealthNet Transcultural Psychosocial Organization · Updated on 2026-01-20
250
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
Sponsors
H
HealthNet Transcultural Psychosocial Organization
Lead Sponsor
U
University of York
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a Participatory Learning and Action (PLA) based intervention aimed at preventing and controlling Type II Diabetes Mellitus (TIIDM) in rural Kabul, Afghanistan. TIIDM is a growing global health emergency, especially in low- and middle-income countries like Afghanistan, where many cases remain undiagnosed. This study aims to adapt and test a culturally appropriate intervention based on evidence from a successful trial in Bangladesh, focusing on the unique social and health challenges in rural Afghan communities. The study involves two groups: one receiving the PLA intervention through group sessions lasting about 2 to 3 hours, designed to engage community members with TIIDM and improve diabetes-related outcomes; and a control group receiving usual care and information about the project but no PLA sessions. Participants in the intervention group will be evaluated 10 months after starting the sessions to assess feasibility and outcomes. Participants will be involved in scheduled meetings and assessments before, during, and after the intervention, using structured and validated checklists to measure feasibility, acceptability, and implementation factors of the PLA approach. The study will also monitor the frequency of Type 2 Diabetes and intermediate hyperglycaemia over 12 months. Overall participation may last up to 12 months, with ongoing evaluation of barriers and facilitators to implementing the intervention in the community.
CONDITIONS
Brief Title
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 20 years and above for the intervention phase
- Individuals aged 30 years and above for baseline and endline assessments
- Residents of randomized clusters in Kabul, Afghanistan
- Willingness to participate and provide consent
- Includes individuals with normal blood sugar, intermediate hyperglycaemia, and diabetes
- Ability to attend scheduled meetings and interventions as per protocol
You will not qualify if you...
- Individuals below 20 years for the intervention phase
- Individuals below 30 years for baseline and endline assessments
- Unwillingness to provide consent
- Health conditions hindering active involvement in the study
- Non-compliance with research protocols
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 10 months
Participants in the intervention group attend Participatory Learning and Action (PLA) sessions lasting approximately 2 to 3 hours each to educate and engage the community for prevention and control of Type II Diabetes.
Group sessions lasting 2 to 3 hours each; frequency as per community schedule
Duration - Up to 2 months after intervention completion
Participants are evaluated using a structured, validated assessment checklist to test feasibility, acceptability, and outcomes of the PLA intervention.
1 to 2 visits for endline assessments
Trial Site Locations
Total: 1 location
1
HealthNet TPO, Afghanistan
Kabul, Kabul, Afghanistan, 24000
Actively Recruiting
Research Team
A
Abdul Rahman Shahab, MPH
S
Sayed Murtaza Sadat Hofiani, MPH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here